February 2, 2018
Cardinal Health sells its China-based subsidiary to Shanghai Pharmaceuticals for $1.2 billion
Cardinal Health has disposed a business unit for $1.2 billion – its Cardinal Health China – to Shanghai Pharmaceuticals Holding.